Nepafenac
- Generic Name
- Nepafenac
- Brand Names
- Ilevro, Nevanac
- Drug Type
- Small Molecule
- Chemical Formula
- C15H14N2O2
- CAS Number
- 78281-72-8
- Unique Ingredient Identifier
- 0J9L7J6V8C
- Background
Nepafenac is a non-steroidal anti-inflammatory prodrug (NSAID) usually sold as a prescription eye drop. It is used to treat pain and inflammation associated with cataract surgery.
- Indication
For the treatment of pain and inflammation associated with cataract surgery.
- Associated Conditions
- Inflammation, Pain
- Associated Therapies
- -
Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery
- First Posted Date
- 2007-06-29
- Last Posted Date
- 2011-07-12
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 82
- Registration Number
- NCT00494494
- Locations
- 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Therapeutic Variables in Cataract Surgery
Phase 4
Completed
- Conditions
- Cataract Surgery
- First Posted Date
- 2006-12-04
- Last Posted Date
- 2007-08-21
- Lead Sponsor
- Innovative Medical
- Registration Number
- NCT00407017
- Locations
- 🇺🇸
The Center for Excellence in Eye Care, Miami, Florida, United States
Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%
Phase 4
Completed
- Conditions
- Vitrectomy
- First Posted Date
- 2006-09-18
- Last Posted Date
- 2008-09-25
- Lead Sponsor
- Innovative Medical
- Registration Number
- NCT00377546
- Locations
- 🇺🇸
Ophthalmic Consultants of Boston, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath